MetaCap

Vogenx Inc (VOGX)

NASDAQ: VOGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.87-0.935 (-7.30%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

VOGX stock chart

Technical analysis

Key statistics

All statistics
Market cap
$176.33M
EPS (TTM)
-$0.89
52-week range
11.51 – 38.41
Day range
11.87 – 13.30
Volume / Avg
100.91K / 128.78K
Beta
—

52-week range

$11.51$38.41

VOGX stock today

Shares of Vogenx (VOGX) finished lower on Nov 20 at $11.87, a drop of 7.30% or $0.935 per share, versus the S&P 500's 3.70% decline. At this level, VOGX sits near the bottom of its 52-week range of $11.51 to $38.41: 69.1% below the high, set on Sep 18, 2026 and 3.1% above the low. Vogenx has posted a net loss over the last twelve months (EPS of -$0.89), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Vogenx

Company profile

Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. James Green
Headquarters
Raleigh, NC
Employees
4
IPO year
2026
Website
vogenx.com

Analyst forecast

Forecast

Consensus (1 analysts)

strong_buy

Avg. price target

$55.00+363.35%

  • Strong buy 0
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 6, 2026
EPS actual vs est.
$-0.47 vs $-0.15
Surprise
-213.33%

VOGX news

All VOGX news

Vogenx peers

Health Care sector
VOGX peer companies
CompanyPrice% ChgMarket capCompare
NATRNature's Sunshine Products Inc.10.18+0.10%$176.41Mvs VOGX
ADCTADC Therapeutics SA1.28-1.54%$180.05Mvs VOGX
SIGASIGA Technologies Inc.2.40-9.43%$172.45Mvs VOGX
SLGLSol-Gel Technologies Ltd.55.17+2.02%$180.63Mvs VOGX
WHWKWhitehawk Therapeutics Inc.3.07-1.60%$181.16Mvs VOGX
TRDAEntrada Therapeutics Inc.4.35-6.25%$170.30Mvs VOGX
KRROKorro Bio Inc.12.18-0.08%$167.18Mvs VOGX
RNACCartesian Therapeutics Inc.6.14+4.24%$187.29Mvs VOGX

Indexes, lists and sector

Vogenx stock FAQ

What is Vogenx's stock price today?

VOGX last traded at $11.87 as of Nov 20, 4:00 PM EST, down 7.30% on the day. Prices are delayed at least 15 minutes.

Who is Vogenx's CEO?

Mr. James Green is the chief executive officer of Vogenx Inc, which has about 4 employees.

What is the VOGX 52-week high?

The 52-week high for VOGX is $38.41 and the 52-week low is $11.51. The stock is currently 69.1% below its high.

Compare VOGX